[Management of the neutropenic and febrile immunocompromised host]

[Article in Spanish]

Review

[Article in Spanish]

A C Barsanti et al. Medicina (B Aires). 1988.

. 1988;48(6):679-94.

No abstract available

Similar articles

Empiric antibiotic therapy in the neutropenic patient.
Boogaerts M. Boogaerts M. Br J Clin Pract Suppl. 1988 Feb;57:85-90. Br J Clin Pract Suppl. 1988. PMID: 3140885 Review. No abstract available.
[Evaluation of antibiotics in febrile neutropenic patients with cancer].
Villegas JB, Gavilán MG. Villegas JB, et al. Rev Esp Quimioter. 1999 Jun;12(2):104-6. Rev Esp Quimioter. 1999. PMID: 10562669 Review. Spanish. No abstract available.
Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K. Tamura K. Int J Antimicrob Agents. 2005 Dec;26 Suppl 2:S123-7; discussion S133-40. doi: 10.1016/j.ijantimicag.2005.08.001. Epub 2005 Oct 24. Int J Antimicrob Agents. 2005. PMID: 16249072
Response rates to a staged antibiotic regimen in febrile neutropenic patients.
Barnes RA, Rogers TR. Barnes RA, et al. J Antimicrob Chemother. 1988 Nov;22(5):759-63. doi: 10.1093/jac/22.5.759. J Antimicrob Chemother. 1988. PMID: 3209532
Empirical antibiotics for febrile neutropenic cancer patients.
Hathorn JW. Hathorn JW. Eur J Cancer Clin Oncol. 1989;25 Suppl 2:S43-51. Eur J Cancer Clin Oncol. 1989. PMID: 2693109 Review.